Ví dụ về việc sử dụng Therapy should be continued trong Tiếng anh và bản dịch của chúng sang Tiếng việt
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
Lisinopril therapy should be continued for 6 weeks.
After the disappearance of the symptoms of the disease andreceiving a negative mycological test, therapy should be continued for at least 7 days.
Therapy should be continued as long as the favorable response lasts.
Due to the fact that premature drug withdrawal leads to relapse,drug therapy should be continued until the onset of clinical and hematological remission.
Therapy should be continued for at least six months and up to 18 months.
In order to prevent the recurrence of this disease, the therapy should be continued after the complete disappearance of all clinical symptoms for another two weeks.
Therapy should be continued until the complete disappearance of the wart.
If, during prophylactic or therapeutic use of the drug, surgical treatment of hemorrhage is performed,intravenous therapy should be continued for at least 5 days after surgery.
The suppressive therapy should be continued for 8 weeks after leaving the endemic area.
Therapy should be continued for 7 days(minimum) after the disappearance of signs of the disease.
If a new manic, mixed or depressive episode arises,olanzapine therapy should be continued(if necessary, correcting the dose), resorting to additional therapy to treat mood disorders in accordance with clinical need.
Therapy should be continued until the affected nail is completely replaced with a healthy one;
In the future, therapy should be continued with the use of enteral forms of the drug.
Therapy should be continued until complete recovery and after the rejection of the affected nail(usually for 2-3 months).
Chelation therapy should be continued until all of the following criteria are satisfied.
Therapy should be continued for at least 14 days after the disappearance of signs of the disease or upon receipt of a negative blood culture;
Anti-asthma therapy should be continued for at least 2 weeks after starting ketotifen.
Therapy should be continued for approximately 14 days, or until more specific therapy may be substituted for a proven infection, or until the patient has been afebrile for 24 hours after the absolute neutrophil count has been greater than 500 cells/mm3.
In this case, therapy should be continued with a different medication that does not contain preservatives.
Therapy should be continued until the infecting organism is completely eradicated as indicated by appropriate clinical or laboratory examination. Treatment periods are at least 2 to 8 weeks for infections of the hair and skin, up to 6 months for infections of the fingernails, and 12 months or more for infections of the toenails.
High-Dose therapy should be continued only until the patient's condition has stabilized and usually should not be continued beyond 48-72 hours.
Therapy should be continued for approximately 14 days, or until more specific therapy may be substituted for a proven infection, or until the patient has been afebrile for 24 hours after the absolute neutrophil count has been greater than 500 cells/mm3.
Therapy should be continued for approximately 14 days, or until more specific therapy may be substituted for a proven infection, or until the patient has been afebrile for 24 hours after the absolute neutrophil count has been greater than 500 cells/mm3.
Continued therapy should be carefully reconsidered in a patient not responding within this time period.
The patient's response to treatment and need for continued therapy should be re-evaluated on a regular basis.
This should be continued throughout your therapy cycles and for at least three weeks following completion of ALIMTA treatment.
Therapy should be initiated(or continued if renal impairment develops while on therapy) with extreme caution and intensive monitoring of hemoglobin concentrations, with corrective action as may be necessary, should be employed throughout the treatment period.